WATCH: Kim A. Reiss Binder, MD, of @pennmedicine.bsky.social, spotlights the mechanism of action of the @fda.gov-approved daraxonrasib for previously treated metastatic pancreatic adenocarcinoma. #pancsm #oncology
Read the full approval story on our site ➡️: www.onclive.com/view/fda-app...
WATCH: Kim A. Reiss Binder, MD, of @pennmedicine.bsky.social, spotlights the mechanism of action of the @fda.gov-approved daraxonrasib for previously treated metastatic pancreatic adenocarcinoma. #pancsm #oncology Read the full approval story on our site ➡️: www.onclive.com/view/fda-app...
0 vue
Publié le 26/08/2026 18:03
WATCH: Kim A. Reiss Binder, MD, of @pennmedicine.bsky.social, spotlights the mechanism of action of the @fda.gov-approved daraxonrasib for previously treated metastatic pancreatic adenocarcinoma. #pancsm #oncology
Read the full approval story on our site ➡️: www.onclive.com/view/fda-app...
0 commentaire
?